An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

Liver Awareness Month, observed each October, increases public understanding of the causes, symptoms, and outcomes of liver disease and highlights steps that can be taken at both the individual and ...

The level of serum duplex-linear DNA (dlDNA) increases markedly with liver disease progression and development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) ...

Chronic inflammation of the liver is a slow, silent disease that can ultimately lead to scarring, cirrhosis, and even liver ...

PHOENIX — The oral medication resmetirom significantly improved liver stiffness and reduced portal hypertension in metabolic ...

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...

Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.